https://en.sputniknews.africa/20240901/unicef-launches-emergency-tender-for-mpox-vaccines-to-aid-crisis-hit-countries-1068096277.html
UNICEF Launches Emergency Tender for Mpox Vaccines to Aid Crisis-Hit Countries
UNICEF Launches Emergency Tender for Mpox Vaccines to Aid Crisis-Hit Countries
Sputnik Africa
The declaration of mpox as a global public health emergency by WHO earlier this month followed an outbreak in the DR Congo that spread to neighboring... 01.09.2024, Sputnik Africa
2024-09-01T10:18+0200
2024-09-01T10:18+0200
2024-09-02T18:45+0200
republic of the congo (congo)
burundi
sweden
united nations children's fund (unicef)
world health organization (who)
health
healthcare
vaccine
mpox (monkeypox)
international
https://cdn1.img.sputniknews.africa/img/07e8/09/01/1068096373_0:320:3072:2048_1920x0_80_0_0_b94d9438e40f91122ca582c3cbd46529.jpg
In a collaborative effort to combat the mpox outbreak, UNICEF, in partnership with Gavi, the Africa CDC, and the World Health Organization (WHO), has issued an emergency tender for mpox vaccines to ensure swift access to life-saving vaccines for countries hardest hit by the recent surge in cases.The tender outlines the potential for agreements with vaccine manufacturers for up to 12 million doses through 2025, depending on production capacity.UNICEF will utilize conditional supply agreements, allowing for immediate purchase and shipment of vaccines once financing, demand, readiness, and regulatory requirements are met.WHO is currently reviewing information submitted by manufacturers regarding two vaccines – one produced by Bavarian Nordic and another by Japan's KM Biologics – for potential emergency use listing. A decision on emergency licenses is expected by mid-September.
https://en.sputniknews.africa/20240831/russia-successfully-tests-mpox-screening-kits-in-republic-of-congo-1068093462.html
republic of the congo (congo)
burundi
sweden
thailand
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2024
Muhammad Nooh Osman
https://cdn1.img.sputniknews.africa/img/07e7/04/0a/1058467512_0:0:1280:1280_100x100_80_0_0_ec723833bcbfcaed2e21952965ad99e4.jpg
Muhammad Nooh Osman
https://cdn1.img.sputniknews.africa/img/07e7/04/0a/1058467512_0:0:1280:1280_100x100_80_0_0_ec723833bcbfcaed2e21952965ad99e4.jpg
News
en_EN
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Muhammad Nooh Osman
https://cdn1.img.sputniknews.africa/img/07e7/04/0a/1058467512_0:0:1280:1280_100x100_80_0_0_ec723833bcbfcaed2e21952965ad99e4.jpg
republic of the congo (congo), burundi, sweden, united nations children's fund (unicef), world health organization (who), health, healthcare, vaccine, mpox (monkeypox), international, thailand
republic of the congo (congo), burundi, sweden, united nations children's fund (unicef), world health organization (who), health, healthcare, vaccine, mpox (monkeypox), international, thailand
UNICEF Launches Emergency Tender for Mpox Vaccines to Aid Crisis-Hit Countries
10:18 01.09.2024 (Updated: 18:45 02.09.2024) Muhammad Nooh Osman
Writer/Editor
The declaration of mpox as a global public health emergency by WHO earlier this month followed an outbreak in the DR Congo that spread to neighboring countries. Congo has reported over 18,000 suspected cases and 629 deaths, while over 150 cases have been confirmed in Burundi. Cases of the virus have also been confirmed in Sweden and Thailand.
In a collaborative effort to combat the
mpox outbreak, UNICEF, in partnership with Gavi, the Africa CDC, and the World Health Organization (WHO), has issued an emergency tender for mpox vaccines to ensure swift access to life-saving vaccines for countries hardest hit by the recent surge in cases.
The tender outlines the potential for agreements with vaccine manufacturers for up to 12 million doses through 2025, depending on production capacity.
UNICEF will utilize conditional supply agreements, allowing for immediate purchase and shipment of vaccines once financing, demand,
readiness, and regulatory requirements are met.
WHO is currently reviewing information submitted by manufacturers regarding two vaccines – one produced by Bavarian Nordic and another by Japan's KM Biologics – for potential emergency use listing. A decision on emergency licenses is expected by mid-September.
